|
|
Previous Article | Table of Contents | Next Article 
Two distinct pathways of interleukin-5 synthesis in allergen-specific human
T-cell clones are suppressed by glucocorticoids
A Mori, O Kaminuma, M Suko, S Inoue, T Ohmura, A Hoshino, Y Asakura, K Miyazawa, T Yokota, Y Okumura, K Ito and H Okudaira
Department of Medicine, Faculty of Medicine, University of Tokyo,
Bunkyo-ku, Japan.
Glucocorticoids (GC) have long been used as the most effective agents for
the treatment of allergic diseases accompanied by eosinophilia such as
chronic asthma and atopic dermatitis. The development of chronic
eosinophilic inflammation is dependent on interleukin-5 (IL-5), a selective
eosinophil-activating factor, produced by helper T cells. To delineate the
regulatory mechanisms of human IL-5 synthesis, we established
allergen-specific CD4+ T-cell clones from asthmatic patients. GC
efficiently suppressed IL-5 synthesis of T-cell clones activated via either
T-cell receptor (TCR) or IL-2 receptor (IL-2R). Induction of IL-5 mRNA upon
TCR and IL-2R stimulation was totally inhibited by dexamethasone. Human
IL-5 promoter/enhancer-luciferase gene construct transfected to T-cell
clones was transcribed on either TCR or IL-2R stimulation and was clearly
downregulated by dexamethasone, indicating that the approximately 500-bp
human IL-5 gene segment located 5' upstream of the coding region contains
activation- inducible enhancer elements responsible for the regulation by
GC. Electrophoretic mobility shift assay analysis suggested that AP-1 and
NF-kappaB are among the possible targets of GC actions on TCR- stimulated T
cells. NF-AT and NF-kappaB were not significantly induced by IL-2
stimulation. Our results showing that GC suppressed IL-5 production by
human CD4+ T cells activated by two distinct stimuli, TCR and IL-2R
stimulation, underscore the efficacy of GC in the treatment of allergic
diseases via suppression of T-cell IL-5 synthesis.
Volume 89,
Issue 8,
pp. 2891-2900,
04/15/1997
Copyright © 1997 by The American Society of Hematology

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
A. C. Liberman, J. Druker, D. Refojo, F. Holsboer, and E. Arzt
Glucocorticoids inhibit GATA-3 phosphorylation and activity in T cells
FASEB J,
May 1, 2009;
23(5):
1558 - 1571.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Camateros, M. Tamaoka, M. Hassan, R. Marino, J. Moisan, D. Marion, M.-C. Guiot, J. G. Martin, and D. Radzioch
Chronic Asthma-induced Airway Remodeling Is Prevented by Toll-like Receptor-7/8 Ligand S28463
Am. J. Respir. Crit. Care Med.,
June 15, 2007;
175(12):
1241 - 1249.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Nishigaki, S. Fujiuchi, Y. Yamazaki, H. Matsumoto, A. Takeda, Y. Fujita, K. Okamoto, T. Fujikane, T. Shimizu, and K. Kikuchi
Increased vascular endothelial growth factor in acute eosinophilic pneumonia
Eur. Respir. J.,
May 1, 2003;
21(5):
774 - 778.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. Y. Almawi and O. K. Melemedjian
Molecular mechanisms of glucocorticoid antiproliferative effects: antagonism of transcription factor activity by glucocorticoid receptor
J. Leukoc. Biol.,
January 1, 2002;
71(1):
9 - 15.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Mori, O. Kaminuma, K. Miyazawa, K. Ogawa, H. Okudaira, and K. Akiyama
p38 Mitogen-Activated Protein Kinase Regulates Human T Cell IL-5 Synthesis
J. Immunol.,
November 1, 1999;
163(9):
4763 - 4771.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. R. Johnson and B. S. Graham
Secreted Respiratory Syncytial Virus G Glycoprotein Induces Interleukin-5 (IL-5), IL-13, and Eosinophilia by an IL-4-Independent Mechanism
J. Virol.,
October 1, 1999;
73(10):
8485 - 8495.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Wargnier, C. Lafaurie, S. Legros-Maida, J.-F. Bourge, F. Sigaux, M. Sasportes, and P. Paul
Down-regulation of Human Granzyme B Expression by Glucocorticoids. DEXAMETHASONE INHIBITS BINDING TO THE Ikaros AND AP-1 REGULATORY ELEMENTS OF THE GRANZYME B PROMOTER
J. Biol. Chem.,
December 25, 1998;
273(52):
35326 - 35331.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
O. Kaminuma, A. Mori, K. Ogawa, K. Wada, H. Kikkawa, K. Naito, M. Suko, and H. Okudaira
Two Differential Effects of Cyclic Adenosine 3',5'-Monophosphate on IL-5 Production by Antigen-Specific Human T Cell Line
J. Pharmacol. Exp. Ther.,
October 1, 1997;
283(1):
345 - 349.
[Abstract]
[Full Text]
|
 |
|
|
|